Pudong, China

Erli You

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erli You. Retrieved from https://idiyas.com/inventor/erli-you-i24oqivv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Erli You - Innovator in FXR Small-Molecule Agonists

Introduction

Erli You is a prominent inventor based in Pudong, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of small-molecule agonists. His work focuses on creating compounds that can be used in the treatment of diseases related to the farnesoid X receptor (FXR).

Latest Patents

One of Erli You's notable patents is titled "FXR small-molecule agonist, and preparation method therefor and use thereof." This patent describes a strong FXR small-molecule agonist, along with its preparation method and potential uses. The structure of the agonist is represented by a specific formula, with each substituent defined in the accompanying description and claims. The compound boasts advantages such as high FXR agonist activity, simple synthesis, and the use of easily available raw materials. It holds promise for preparing medicines aimed at treating FXR-related diseases.

Career Highlights

Erli You is affiliated with the Chinese Academy of Sciences, where he conducts his research and development activities. His work has garnered attention for its innovative approach to drug development and its potential impact on healthcare.

Collaborations

Erli You collaborates with fellow researcher Huaqiang Xu, contributing to advancements in their shared field of study.

Conclusion

Erli You's contributions to the field of medicinal chemistry, particularly through his patent on FXR small-molecule agonists, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in treating FXR-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…